supplier
Tetris Pharma Lts
as a supplier
7 recorded awards from 3 buyers , between 23 Apr 2023 and 4 Mar 2024.
awards won
7
exclusive
0%
0 sole-winner awards
median award
£214.1m
largest
£428.2m
“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.
sells to
| buyer | awards |
|---|---|
| NHS England | 5 |
| Atamis Ltd | 1 |
| The NHS Commissioning Board (operating under the name of NHS England) | 1 |
contracts won
| contract | buyer | value | awarded |
|---|---|---|---|
| NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2) shared | NHS England | £1 | 4 Mar 2024 |
| NHS National Generic Pharmaceuticals Wave 14b shared | ATAMIS LTD | £428,226,984 | 6 Jul 2023 |
| NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared | NHS England | £304,504,000 | 23 Apr 2023 |
| NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals shared | NHS England | · | 6 Apr 2023 |
| NHS National Generic Pharmaceuticals Wave 13 shared | The NHS Commissioning Board (operating under the name of NHS England) | · | 14 Jan 2022 |
| NHS Framework Agreement, Branded Medicines for London and South of England shared | NHS England | · | 17 Sept 2021 |
| NHS Framework Agreement, Branded Medicines for London and South of England shared | NHS England | · | 17 Sept 2021 |